Prevalence of left ventricular hypertrophy and carotid thickening in a large selected hypertensive population: Impact of different echocardiographic and ultrasonographic diagnostic criteria

Blood Pressure

Volumn 10, Issue 3, 2001, Pages 142-149

  Cuspidi, C ^a   Lonati, L ^a   Macca, G ^a   Sampieri, L ^a   Fusi, V ^a   Michev, I ^a   Severgnini, B ^a   Salerno, M ^a   Magrini, F ^a   Zanchetti, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Carotid intima media thickening; Essential hypertension; Hypertension clinic; Left ventricular hypertrophy

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; BODY HEIGHT; BODY SURFACE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; EVALUATION; FEMALE; HEART INDEX; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PARTITION COEFFICIENT; PATIENT REFERRAL; PATIENT SELECTION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SAMPLE; STANDARDIZATION; ULTRASOUND;

ADULT; AGED; AGED, 80 AND OVER; CAROTID ARTERIES; CAROTID ARTERY DISEASES; COHORT STUDIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PREVALENCE; REFERENCE STANDARDS; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA; ULTRASONOGRAPHY;

EID: 17944370253     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/080370501753182352     Document Type: Article

References (39)

1. The Sixth Report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure
2. World Health Organization-International Society of Hypertension guidelines for the management of hypertension. Guidelines Subcommittee
3. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy
4. Clinical impact of twenty years of research on left ventricular hypertrophy
5. Detection of preclinical atherosclerosis may optimize the management of hypertension
6. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension
7. Prognostic implications of echocardiographically determined left ventricualr mass in the Framingham heart study
8. Comparison of classification of hypertension by blood pressure level and World Health Organization Criteria for prediction of concurrent cardiac abnormalities and subsequent complications in essential hypertension
9. The relative effects of left ventricular hypertrophy coronary artery disease, and ventricular dysfunction on survival among black adults
10. Prevalence of carotid atherosclerosis in hypertension: Preliminary baseline data from the European Lacidipine Study on Atherosclerosis
11. Clinical Results of the Verapamil in Hypertension and Atherosclerosis Study
12. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease
13. The role of carotid arterial intima-media thickness in predicting clinical coronary events
14. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults
15. The Verapamil in Hypertension and Atherosclerosis Study (VHAS): Results of long-term randomized treatment with either Verapamil or Chlorthalidone on carotid intima-media thickness
16. The prevalence and correlation of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension
17. Prevalence of target organ damage in treated hypertensive patients: Different impact of clinical and ambulatory blood pressure control
18. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults
19. Importance of obesity, race and age to the cardiac structural and functional effect of hypertension
20. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
21. Echocardiographic determination of the left ventricular mass in man: Anatomic validation of the method
22. Results of the RACE (Ramipril cardioprotective evaluation) study
23. Left ventricular mass and function in primary hypertension
24. Effect of growth on variability of left ventricular mass: Assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk
25. Patterns of left ventricular hypertrophy and geometric remodelling in essential hypertension
26. Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging
27. Measurement of intima-media thickness of common carotid arteries with high resolution B-mode ultrasonography: Inter and intraobserver variability
28. Vascular wall thickness in hypertension: The Perindopril Regression of vascular thickening European Community trial (PROTECT)
29. Lack of correlation between left ventricular mass and diameter of left coronary artery main trunk in hypertensive patients
30. Echocardiographic and ultrasonographic evaluation of cardiac and vascular hypertrophy in patients with essential hypertension
31. Clinical assessment of cardiac hypertrophy
32. Population implications of electro-cardiographic left ventricular hypertrophy
33. Electrocardiographic detection of left ventricular hypertrophy using echocardiographic determination of left ventricular mass as the reference standard
34. The impact of different echocardiographic diagnostic criteria on the prevalence of left ventricular hypertrophy in essential hypertension. The VITAE study
35. Impact of different partition values on prevalence of left ventricular hypertrophy and concentric geometry in a large hypertensive population. The LIFE study
36. Evidence for in vivo carotid and femoral wall thickening in human hypertension
37. Association of carotid atherosclerosis and left ventricular hypertrophy
38. Baseline data from the European Lacidipine Study on Atherosclerosis
39. Guidelines for arterial hypertension: The echocardiography controversy